Continual advancements in cardiac imaging technologies contribute to improved diagnostic accuracy, early disease detection, and better patient outcomes. Positron emission tomography (PET) imaging, for instance, provides functional information about myocardial metabolism and blood flow, aiding in the assessment of heart conditions. 3D echocardiography enhances the visualization of cardiac structures, allowing for more precise evaluation of heart valve function and anatomical anomalies. Cardiac imaging is not only valuable in the diagnostic phase but also plays a vital role in guiding interventional procedures, such as angioplasty or transcatheter valve replacement. The integration of artificial intelligence (AI) in cardiac imaging further enhances efficiency and accuracy by assisting in image analysis and interpretation. As the field continues to evolve, cardiac imaging remains an indispensable tool in the comprehensive care of individuals with cardiovascular diseases, enabling healthcare providers to make informed decisions and tailor treatment strategies to each patient's specific needs.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India